Trial Profile
The Effect of Dexmedetomidine on the Microcirculation in Patients With Severe Sepsis and Septic Shock
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Midazolam; Propofol
- Indications Sepsis; Septic shock
- Focus Pharmacodynamics
- 28 Feb 2019 Status changed from recruiting to discontinued.
- 20 Dec 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 20 Dec 2016 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.